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Objective. To determine if sex-specific differences 
in lymphocyte trafficking could contribute to increased 
disease severity in female mice. 
Methods. A lupus-like disease was induced by 
injecting male and female mice with procainamide- 
treated T cell clones. Trafficking was examined by labeling 
the injected cells with 'lCr or 5-chloromethylfluorescein 
diacetate. 
Results. Females developed more autoimmune 
liver disease and greater titers of anti-DNA antibodies 
than did males, and 2-7 times more cells accumulated 
in the female spleens. Splenectomy prevented the devel- 
opment of autoantibodies and renal and liver disease. 
Oophorectomy decreased the splenic homing, autoanti- 
body titer, and liver disease severity, to levels found in 
males. 
Conclusion. T cells traffic differently to the spleen 
in male and female mice, and the spleen appears to be 
essential in the disease process. This suggests that 
differences in T cell homing could contribute to sex- 
specific disease severity in this murine model, and also 
possibly in human disease. 
Systemic lupus erythematosus is an idiopathic 
autoimmune disease that primarily affects women (1). 
Extensive studies have implicated female sex hormones 
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in disease susceptibility, suggesting that estrogen- 
dependent effects such as increased cell-rnediated im- 
munity and increased antibody responses play a role in 
disease severity (2,3). However, despite intensive inves- 
tigation, the mechanisms causing the increased immune 
responsiveness and sex-specific disease manifestations 
are unknown. 
Our group has described a novel lupus model in 
which D10 cells, a cloned murine antigen-specific T 
helper 2 line, are made autoreactive by treatment with 
DNA methylation inhibitors such as procainamide 
(Pca), then given in adoptive transfer to nonirradiated 
syngeneic recipients (AKR mouse strain). The autore- 
active cells interact with other cells of the immune 
system, lysing macrophages and inducing B cell differ- 
entiation (4-6). The recipients subsequently develop an 
immune complex glomerulonephritis, pulmonary alve- 
olitis, a liver disease resembling primary biliary cirrhosis, 
and autoantibodies to single-stranded DNA (ssDNA) 
and double-stranded DNA (dsDNA) (4), by a mecha- 
nism resembling that of chronic graft-versus-host disease 
(7,s). A lupus-like disease can also be induced using 
polyclonal DBN2 CD4+ T cells and syngeneic recipi- 
ents (5 ) ,  indicating that induction of autoimmunity by 
this mechanism is not unique to D10 cells or to the AKR 
strain. 
The autoreactivity that is induced in vitro and 
lupus-like disease that develops in vivo can be directly 
attributed to the overexpression of lymphocyte function- 
associated antigen 1 (LFA-l), which is caused by the 
drug treatment (8). LFA-1 is an adhesion molecule that 
binds intracellular adhesion molecule 3 (ICAM-1) on 
other cell types, including endothelial cells (9). A recent 
study demonstrated that estrogens can increase expres- 
sion of endothelial adhesion molecules, including 
E-selectin, ICAM-1, and vascular cell adhesion molecule 
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1 (lo), and others have shown that endothelial cells in 
different tissues can express different surface proteins 
(1 1). This raises the intriguing possibility that estrogens 
may affect T cell trafficking patterns by altering endo- 
thelial adhesion molecule expression in an organ- 
specific manner. 
We sought to determine whether sex-specific 
differences in T cell trafficking could affect the severity 
of disease manifestations in this murine lupus model. 
We used the D10 model to correlate sex-specific disease 
manifestations with differences in T cell homing be- 
tween male and female recipients. The  results indicated 
a crucial role for splenic homing in this model, and 
demonstrated a sex-specific difference in the number of 
T cells accumulating in the spleen, which can explain the 
differences in disease severity between male and female 
mice. These results support the  very interesting concept 
that T cells can traffic differently to lymphoid tissues in 
males and females. Our findings raise the possibility that 
this difference in trafficking can contribute to sex- 
specific disease manifestations. 
MATERIALS AND METHODS 
Mice. Six-to-8-week-old female and male AKR mice 
were purchased from Jackson Laboratories (Bar Harbor, ME) 
and maintained in a pathogen-free environment provided by 
the Unit for Laboratory Animal Medicine at the University of 
Michigan. Splenectomy, oophorectomy, and orchiectomy were 
performed on adult (6-8-week-old) mice by personnel at 
Jackson Laboratories. These mice were allowed to recover for 
at least 4 weeks before use in adoptive transfer protocols. All 
mice were killed by 8 months of age, and samples were 
extracted for histologic analysis and measurement of 
autoantibodies. 
Cells and cell culture. D10.G4.1 cells (12) were ob- 
tained from American Type Culture Collection (Rockville, 
MD) and cultured as previously described (43). D10 cells are 
conalbumin specific, express interleukin-4 (IL-4), IL-6, and 
IL-I 0, and do not express Fas ligand or perforin. Because of a 
report that indicated that the D10 line may contain an auto- 
reactive subset (13), the cells were subcloned by limiting 
dilution at 0.2 cells/well, and a nonautoreactive subclone was 
selected for use in these studies. Where indicated, 50 f l  Pca 
(Sigma, St. Louis, MO) was added 1 day after restimulation, 
and the cells were used for adoptive transfer or homing studies 
6 days later. 
Cell labeling. D10 cells were labeled with "Cr by 
culturing lo7 cells with 100 &i ["Crl-Na,Cr,O, (New En- 
gland Nuclear, Boston, MA) in 1 ml at 37°C for 1 hour. The 
cells were then washed 3 times with RPMI 1640 (Gibco, Grand 
Island, NY). Other D10 cells were labeled with 5- 
chloromethylfluorescein diacetate (CMFDA) (Molecular 
Probes, Eugene, OR) using the protocol provided by the 
manufacturer. 
Adoptive transfer. For homing experiments, 5 x 10" 
5'Cr- or CMFDA-labeled D10 cells were injected intrave- 
nously via the tail vein, and the mice were killed 24 or 48 hours 
later. For disease induction, 6 intravenous injections of 5 x lo6 
drug-treated or untreated D10 cells were administered in 
2-week intervals to the mice in groups of 5. Four weeks after 
the last injection, these mice were killed. 
Lymphocyte homing. "Cr-labeled cells in various tis- 
sues were detected by first weighing the tissue samples and 
then measuring gamma emissions using a Gamma Trac 1191 
gamma spectrometer (Tracor Analytic, Elk Grove Village, IL). 
CMFDA-labeled D10 cells were detected by staining spleno- 
cytes with phycoerythrin (PE)-conjugated anti-CD4 (Phar- 
Mingen, San Diego, CA), then enumerating cells expressing 
both CD4 and CMFDA with a Coulter (Hialeah, FL) ELITE 
flow cytometer, analyzing at least 106 cells per sample. 
Cytofluorography. Untreated or Pca-treated D10 cells 
were reacted with fluorescein isothiocyanate (FITC)- 
conjugated antibodies to MEL-14, as previously described 
(14). These cells were then analyzed with a Coulter ELITE 
flow cytometer. 
Histologic analysis. Tissues were prepared and stained 
with hematoxylin and eosin as previously described (43). 
Direct immunofluorescence studies were performed on frozen 
sections of the liver, lung, and kidney, as previously described 
( 4 3 ,  using FITC-conjugated goat anti-mouse Ig (GAM-FITC; 
Sigma). Indirect immunofluorescence was performed by react- 
ing frozen sections of normal liver and lung with 1:20 and 1:80 
dilutions of mouse sera, followed by washing and staining with 
GAM-FITC, as was done for direct immunofluorescence. 
Autoantibody assays. Total serum IgG and IgM con- 
centrations as well as anti-ssDNA and anti-dsDNA antibodies 
were measured by enzyme-linked immunosorbent assay 
(ELISA), using previously described protocols (4,5,8) and 
peroxidase-conjugated polyvalent or y-chain-specific antibod- 
ies from Sigma. Positive controls included pooled serum from 
26-month-old female New Zealand black X New Zealand 
white (NZB X NZW) mice, similar to that used in previous 
experiments (4,5,8). All determinations were performed in 
quadruplicate. 
Statistical analysis. Differences between groups were 
analyzed using Student's 2-tailed t-test or chi-square analysis 
with Yates' correction. 
RESULTS 
Effects of Pca-treated D10 cells in male and 
female mice. Initial experiments compared the effects of 
untreated and Pca-treated D10 cells in male and female 
syngeneic (AKR) mice. Each group received 6 intrave- 
nous injections of treated or untreated cells. Four weeks 
after the last injection, the mice were killed and  exam- 
ined for serologic and histologic evidence of autoimmu- 
nity. Figures 1A and B compare the total anti-ssDNA 
and anti-dsDNA antibody responses in the  4 groups. 
Male and female mice receiving untreated cells pro- 
duced no significant amounts of either autoantibody. 
Female mice receiving Pca-treated cells produced signif- 
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Figure 1. Anti-DNA antibody responses in male and female mice. A, Sera from male mice receiving untreated D10 cells (CM), male mice 
receiving procainamide (Pca)-treated cells (PM), female mice receiving untreated cells (CF), or female mice receiving Pca-treated cells (PF) 
were tested for antibodies to single-stranded DNA (anti-ssDNA) by enzyme-linked immunosorbent assay (ELISA). B, Sera from the same 
mice as in A were tested for anti-double-stranded DNA (anti-dsDNA) antibodies by ELISA. C, Sera from female mice receiving untreated 
D10 cells, female mice receiving Pca-treated cells, oophorectomized mice receiving Pca-treated cells (OPF), male mice receiving untreated 
D10 cells, male mice receiving Pca-treated cells, or castrated male mice receiving Pca-treated cells (CPM) were tested for anti-ssDNA 
antibodies by ELISA. D, Sera from the same mice as in C were tested for anti-dsDNA antibodies by ELISA. Each circle represents the mean 
of quadruplicate determinations on serum from a single mouse. Squares and error bars show the mean 2 SEM values for each group of mice. 
O.D. = optical density. 
icantly more anti-ssDNA antibodies than did males 
receiving the same cells ( P  < 0.05). A similar trend was 
observed for titers of anti-dsDNA antibodies, whereby 
female mice produced higher titers than were found in 4 
of the 5 male mice tested. These results were confirmed 
in second experiments €or both anti-ssDNA and anti- 
dsDNA (Figures 1C and D; P < 0.001 for male versus 
female mice receiving Pca-treated cells). 
Using an IgG-specific ELISA, the anti-ssDNA 
and anti-dsDNA responses in female mice receiving 
untreated D10 cells were 0.202 ? 0.030 and 0.238 ? 
0.031 (mean ? SEM optical density [OD] units), respec- 
tively, while females receiving Pca-treated cells mounted 
a greater response (anti-ssDNA 0.327 f 0.042, P < 0.05; 
anti-dsDNA 0.502 ? 0.073, P < 0.01). In contrast, no 
significant increase in the IgG anti-ssDNA or anti- 
dsDNA responses was seen in the male mice after 
receiving Pca-treated cells (antisDNA 0.136 2 0.017 
versus 0.143 ? 0.028; anti-dsDNA 0.056 f 0.032 versus 
0.093 _t 0.029). The difference between the male and 
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Figure 2. Histologic analysis of liver specimens from male and female 
mice. A, Representative fiver section from a female mouse receiving 
procainamide (Pca)-treated D10 cells, showing lymphocytic periductal 
inflammation. B, Representative liver section from a male mouse 
receiving Pca-treated cells. The liver appears normal. C, Representa- 
tive liver section from an oophorectomized female mouse receiving 
Pca-treated cells, showing very mild periductal inflammation. D, 
Representative liver section from an orchiectomized male mouse, 
showing a lymphocytic inflammatory infiltrate adjacent to a bile duct. 
(Hematoxylin and eosin stained, original magnification X 200.) 
female IgG anti-ssDNA responses was significant (P < 
0.01), as were the IgG anti-dsDNA sex-specific re- 
sponses (P  < 0.001). Quantitation of total IgG and IgM 
by ELISA showed no significant differences between the 
mice receiving treated cells and those receiving un- 
treated cells, as reported previously (4,S,8), indicating 
that the differences in autoantibody titers were not a 
result of polyclonal B cell activation. 
Histologic analysis revealed both renal and pul- 
monary disease in male and female mice (previously 
reported in ref. 4). However, although periductal inflam- 
mation was observed in female mice receiving Pca- 
treated cells (Figure 2A), but not in female mice receiv- 
ing untreated D10 cells (previously reported in ref. 4), 
none of the male mice developed liver disease (Figure 
2B) (P < 0.00s). To exclude the possibility that the 
male mice mounted an antibody response to as-yet- 
unidentified determinants on the D10 cells, which would 
result in elimination of the transferred cells and subse- 
quent diminished effect, evidence for anti-D10 antibod- 
ies was sought. Sera from the 4 groups were diluted 
1:100 and then allowed to bind D10 cells. Bound Ig was 
detected using FITC-conjugated anti-mouse Ig, and 
quantitated using flow cytometry. No difference in stain- 
ing of the D10 cells was found between male and female 
mice. Together, these results demonstrated that D10 
cells cause significantly higher-titer anti-DNA antibodies 
and greater frequency of autoimmune liver disease in 
female mice compared with male mice. 
Gonadal effects in this system were examined by 
comparing serologic and histologic evidence of autoim- 
munity in normal and oophorectomized females, and in 
normal and orchiectomized males. Figures 1C and D 
show the differences in anti-ssDNA and anti-dsDNA 
antibody responses in normal mice receiving untreated 
or Pca-treated D10 cells compared with neutered mice 
receiving Pca-treated D10 cells. Oophorectomy resulted 
in a significant decrease in the total anti-ssDNA re- 
sponse in female mice receiving Pca-treated cells (P < 
0.00s). Moreover, a small but statistically insignificant 
decrease in titer was seen in castrated versus normal 
male mice receiving Pca-treated cells. Similar results 
were seen for the anti-dsDNA response in female mice 
receiving Pca-treated cells (P < 0.001, control versus 
oophorectomized mice). The oophorectomized mice re- 
ceiving Pca-treated cells did not mount significant IgG 
responses to ssDNA or dsDNA relative to controls (data 
not shown). However, castrated males produced greater 
total Ig and IgG-specific anti-dsDNA responses than did 
controls (P < 0.02 and P < 0.01, respectively), whereas 
no change was observed in the anti-ssDNA response. 
Earlier reports have indicated that antibody responses to 
dsDNA appear earlier than do responses to other nu- 
cleic acid antigens in castrated male NZB X NZW mice 
(15), thus suggesting an explanation for our findings. 
Histologic evaluation demonstrated pulmonary 
disease in neutered males and females, essentially iden- 
tical to that seen in intact animals. Mild renal disease 
was also seen in both groups. However, in oophorecto- 
mized females, the severity of the liver disease markedly 
decreased (Figure 2C), while periductal inflammation 
was seen in 4 of the 5 castrated males (Figure 2D). These 
results indicate that oophorectomy yields significantly 
decreased autoantibody responses, to levels approximat- 
ing those seen in males. Moreover, oophorectomy de- 
creases the severity of hepatic disease in mice, while 
orchiectomy may increase it. 
Homing of untreated and Pca-treated D10 cells 
in male and female mice. We next analyzed whether 
differences in homing could be correlated with these 
sex-specific differences in disease manifestations. It was 
important to first determine if Pca alters expression of 
MEL-14, a T cell homing molecule that targets lympho- 
cytes to peripheral lymph nodes (16). In a previous study 
using flow cytometry, D10 cells expressed no detectable 
MEL-14, consistent with its down-regulation in “memo- 
ry” T cells (16). In the present study, the treatment of 
D10 cells with Pca, using schedules and concentrations 
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Figure 3. Homing of 51Cr-labeled D10 cells. A, Female mice were injected intravenously with 5 X lo6 "Cr-labeled 
untreated D10 cells or procainamide (Pca)-treated D10 cells. The indicated organs were removed 24 hours later and 
51Cr uptake was determined by measuring gamma emissions. Total counts per minute from the organs shown were 
added together, and results for each organ are expressed as a percentage of this sum. Bars show the mean and SEM 
percentage for 8 mice receiving untreated cells or 9 mice receiving treated cells. B, Female (n = 8-9 per group) or male 
(n = 5 per group) mice received injections of untreated or Pca-treated D10 cells, and homing to the liver, spleen, lung, 
brain, heart, and thymus was measured as described in A. Bars show the mean and SEM percentage of labeled cells 
homing to the spleen. 
known to induce autoimmunity in vivo, did not induce 
expression of MEL-14, indicating that altered expression 
of this molecule does not contribute to autoimmunity in 
this system. 
The effect of Pca treatment on D10 tissue distri- 
bution was then determined. Female AKR mice were 
injected with 5 X lo6 '*Cr-labeled untreated or Pca- 
treated D10 cells as before, then killed 24 or 48 hours 
later. The liver, spleen, lungs, brain, heart, and thymus 
were removed as whole organs, and representative sam- 
ples of mesenteric lymph nodes, salivary glands, skin, 
and muscle were obtained. All tissue samples were 
weighed, and 'lCr content was determined by measuring 
gamma emissions. Overall, at 24 hours, no more than 
1% of the injected radioactivity could be detected in 
mice receiving treated or untreated cells. This decreased 
to 0.6% at 48 hours, suggesting that relatively few cells 
are needed to induce autoimmunity. Figure 3A com- 
pares the homing of untreated D10 cells (n = 8) and 
Pca-treated cells (n = 9) in female AKR mice at 24 
hours. There was no difference in homing of treated and 
untreated cells in any of the organs studied. Overall, the 
liver retained the greatest amount of radioactivity, and 
less, but still significant, amounts were retained by the 
spleen and lung. No significant radioactivity accumu- 
lated in the brain, heart, or thymus. Similarly, no signif- 
icant amount of radioactivity could be detected in the 
lymph nodes, muscle, skin, or salivary gland samples. 




















Figure 4. Splenic homing of 5 X 10' 5-chloromethylfluorescein dia- 
cetate (CMFDA)-labeled D10 cells injected into intact (control) or 
neutered female and male mice. Twenty-four hours later, the spleno- 
cytes were isolated and stained with phycoerythrin-conjugated anti- 
CD4, then CMFDA+ and CD4+ cells were analyzed by flow cyto- 
metry. Results were calculated as (the number of cells bearing both 
markers divided by the total number of CD4+ cells) X 100. Bars show 
the mean and SEM percentage of splenic homing. 
Essentially identical results were observed at 48 hours (4 
mice per group), with similar tissue distribution and 
again no difference between treated and untreated cells. 
The same studies were performed in males, using 
5 mice per group, and performed in parallel with female 
controls. Overall, the same amount of radioactivity was 
retained as in female mice, and again no difference in 
homing was seen between untreated and Pca-treated 
cells. Uptake by the liver, lung, brain, heart, thymus, 
lymph nodes, salivary glands, skin, and muscle was also 
identical to that in the female mice. However, approxi- 
mately twice as much radioactivity accumulated in the 
spleens of female mice compared with male mice. Figure 
3B shows the difference in radioactivity taken up by the 
spleens of female and male mice that had received either 
treated (P < 0.05) or untreated (P < 0.01) D10 cells. 
The difference in radioactivity taken up by the 
spleens of male and female mice could be due to 
differences in D10 trafficking, larger spleens in the 
female mice, or increased uptake of released 51Cr by 
female splenic phagocytic cells. The possibility that 
larger spleen size in female mice contributed to the 
difference was excluded by weighing spleens from both 
male and female mice. There was no significant differ- 
ence in splenic weight between male and female mice 
(mean 2 SEM 87 * 4 mg in 10 males versus 91 -+ 5 mg 
in 18 females). 
To determine if the radioactivity represented 
labeled T cells, splenic homing studies were repeated 
using CMFDA-labeled cells. First, female AKR mice 
were injected with 5 X lo6 CMFDA-labeled control or 
Pca-treated D10 cells. Twenty-four hours later, the mice 
were killed, splenocytes were isolated and stained with 
anti-CD4-PE7 and cytofluorographic analysis was per- 
formed to quantitate cells expressing both CD4 and 
CMFDA. Again, no significant difference in splenic 
homing was observed between treated and untreated 
cells (n = 3 mice/group). These studies were then 
performed in 8 male and 10 female mice, using un- 
treated D10 cells. In female mice, CMFDA-labeled cells 
represented 0.131 * 0.013% of the CD4+ splenocytes, 
while in male mice, they represented 0.018 ? 0.003% 
(I' < 0.001), a 7-fold difference. This difference could 
not be attributed to differences in the total percentage of 
splenic CD4+ T cells in these animals (mean -+ SEM 
50.9 -+ 4.0% in males versus 49.3 2 2.9% in females). 
These results confirm those obtained using "Cr, indi- 
cating that more D10 cells accumulate in the spleens of 
female mice compared with male mice. Attempts were 
also made to detect CMFDA-labeled cells in sections 
from the livers, lungs, and spleens by fluorescence 
microscopy. No fluorescent cells were detected, possibly 
due to the low number of cells surviving injection. 
The effect of male and female castration on 
splenic homing was examined by comparing the results 
in 5 orchiectomized male mice and 4 oophorectomized 
fernale mice with those in normal controls (Figure 4). 
Castration produced a small, but statistically insignifi- 
cant, increase in male splenic homing. However, splenic 
homing in oophorectomized females was significantly 
(P < 0.001) less than in intact females, and not signifi- 
cantly different from that in males. This suggests that 
female sex steroids may influence splenic T cell homing. 
Importance of splenic homing. Although a repro- 
ducible and statistically significant difference in splenic 
accumulation could be seen between normal male and 
female mice, the relevance of splenic homing to autoim- 
munity was uncertain. The importance of splenic horn- 
ing was determined by comparing disease severity in 
splenectomized mice with that in control mice. Intrave- 
nous injections of 5 X lo6 untreated or Pca-treated D10 
cells were administered to control or splenectomized 
female AKR mice using protocols identical to those 
described above. In Figure 5 ,  titers of autoantibodies to 
ssDNA and dsDNA are compared among the 4 groups 
of mice. Figure 5A shows the results of the anti-ssDNA 
1340 
0 .  
YUNG ET AL 
assay. Splenectomized mice receiving Pca-treated cells 
produced anti-ssDNA antibodies in amounts similar to 
those in controls, and produced significantly (P < 0.057) 
less than did intact mice receiving Pca-treated cells. 
IgG-specific ELISAs gave similar results for splenecto- 
mized mice (mean -+ SEM OD units 0.170 -+ 0.016 in 
those receiving untreated cells versus 0.193 ? 0.043 in 
those receiving Pca-treated cells). 
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Figure 5. Anti-DNA antibody responses in splenectomized mice. Sera 
were obtained from female mice receiving untreated D10 cells (CF) or 
procainamide (Pca)-treated cells (PF), or from splenectomized female 
mice receiving untreated D10 cells (SC) or Pca-treated cells (SP). A, 
Sera were analyzed for anti-single-stranded DNA (anti-ssDNA) anti- 
bodies by enzyme-linked immunosorbent assay as in Figure 1. B, The 
same sera were analyzed for anti-double-stranded DNA (anti- 
dsDNA) antibodies as in Figure 1. Each circle represents the mean of 
quadruplicate determinations on serum from a single mouse. Squares 
and error bars show the mean ? SEM values for each group of mice. 
O.D. = optical density. 
Figure 6. Histologic analysis of kidney and liver specimens from 
control and splenectomized mice. A, Glomerulus from a control mouse 
receiving procainamide (Pca)-treated cells. Karyorrhectic debris and 
increased mesangial matrix with obliteration of capillary loops are seen 
(hematoxylin and eosin [H & El stained, original magnification X 
375). B, Representative glomerulus from a splenectomized mouse 
receiving Pca-treated cells. The glomerulus appears normal (H & E 
stained, original magnification X 375). C, Liver section from a normal 
female mouse receiving Pca-treated D10 cells, showing periductal 
inflammation (H &r E stained, original magnification X 200). D, 
Representative liver section from a splenectomized mouse receiving 
Pca-treated cells, showing normal histologic features (H & E stained, 
original magnification X 200). 
lyzed for anti-dsDNA autoantibody responses. Again, 
control mice receiving Pca-treated cells produced signif- 
icantly (P < 0.02) greater amounts of anti-dsDNA than 
did splenectomized mice. Similarly, IgG-specific assays 
demonstrated a significant decrease in the anti-dsDNA 
response in splenectomized mice (mean -+ SEM OD 
units 0.502 ? 0.073 in intact mice versus 0.227 2 0.061 in 
splenectomized mice; P < 0.02). To exclude the possi- 
bility that the differences in autoantibody titers were due 
to polyclonal increases in Ig, levels of total serum IgG 
and IgM were again measured in all 4 groups. No 
significant differences were found, thus ruling out this 
possibility. 
Figure 6 shows representative sections from the 
kidneys and livers of control and splenectomized mice. 
In Figure 6A, karyorrhectic debris and increased mes- 
angial matrix with obliteration of capillary loops can be 
seen in a section from a control mouse receiving Pca- 
treated cells. In other sections, hypercellularity was 
observed. In Figure 6B, the glomerulus appears to be 
normal in a splenectomized mouse receiving Pca-treated 
cells. In Figure 6C, autoimmune liver disease is apparent 
in a normal female mouse after administration of Pca- 
treated D1O cells. In contrast, Figure 6 0  shows a 
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normal-appearing liver sample from a splenectomized 
mouse receiving the same cells. Among all 5 of the 
splenectomized mice receiving Pca-treated cells, none 
developed either liver or kidney disease, while all 5 of 
the controls developed lesions in both of these organs 
after receiving Pca-treated cells (P  < 0.005). 
In contrast to the kidney and liver manifestations, 
no changes were observed in the pulmonary disease. 
Since no anti-DNA antibodies, renal disease, or liver 
disease developed in splenectomized mice, it is possible 
that autoantibodies contributed to the kidney and liver 
disease but splenectomy prevented their generation. 
Frozen sections of the liver, lung, and kidneys of intact 
female mice receiving Pca-treated cells were therefore 
examined for immune complex deposition, by staining 
with GAM-FITC. While immune complexes could be 
readily observed in the kidney (previously reported in 
ref. 4), no immune complex deposition was detected in 
the liver and lung. Indirect immunofluorescence exper- 
iments, in which sera from female mice with liver and 
lung disease were used to stain frozen liver and lung 
sections from normal female AKR mice, also failed to 
demonstrate the presence of autoantibodies. Together, 
these results suggest that the spleen is essential to the 
autoantibody response and to the severity of kidney and 
h e r  disease, but not to pulmonary disease. Moreover, 
these results show that neither the lung disease nor the 
liver disease appeared to involve autoantibodies. 
DISCUSSION 
These experiments have allowed us to make 
several novel observations regarding the relationship 
between sex, autoimmune disease, and T cell homing. 
The initial experiments characterized the sex-specific 
disease manifestations of this system. The female recip- 
ients developed higher titers of autoantibodies, which 
decreased following oophorectomy. Similar results have 
been reported in NZB X NZW mice (17), in which T 
cells were also important for disease development (18). 
However, although the level at which sex affects the 
immune response in the genetic models is uncertain, the 
use of a defined signal in the present model suggests that 
a major effect of sex is at the level of the T cell-host 
interaction, since the stimulus was identical in both male 
and female mice. 
There was also a sex-specific effect on liver 
disease. The liver disease in this model most closely 
resembles human primary biliary cirrhosis, with bile duct 
proliferation and an intense inflammatory infiltrate (4). 
This manifestation had a striking female predilection, 
with all of the female and none of the male mice 
demonstrating abnormalities. The liver disease was ame- 
liorated by oophorectomy, and orchiectomy increased 
the degree of liver damage. This suggests that female sex 
steroids may augment, and male sex steroids suppress, 
this manifestation. Further studies examining the role of 
exogenous sex steroids in this model may shed additional 
light on the pathogenesis of this lesion, as will studies 
characterizing the infiltrating cells. Interestingly, more 
than 95% of patients with primary biliary cirrhosis are 
women, and some have positive antinuclear antibody 
(19), suggesting that this may be a useful model for 
studying this sex-specific disease in humans. 
In contrast to the autoantibody and liver test 
results, the pulmonary disease induced by drug-treated 
cells had no sex predilection, and was not modified by 
neutering or splenectomy. This suggests that pulmonary 
disease is independent of sex steroids and does not 
require homing to lymphoid tissue. It is possible that the 
autoreactive cells, injected intravenously and retained by 
the lung, contributed directly to the pulmonary lesions. 
Future studies using cells with a transgenic marker may 
permit homing studies of longer duration, to examine 
this hypothesis. 
Homing studies demonstrated a sex-specific dif- 
ference in T cell uptake by the spleen, which, to the best 
of our knowledge, has not been previously reported. The 
initial studies used 51Cr-labeled cells, and demonstrated 
no significant differences in the homing of treated or 
untreated cells. The majority of the radioactivity was 
found in the liver, and lesser amounts were found in the 
lung and spleen. This distribution is consistent with that 
seen in earlier studies using the same approach (20), and 
suggests that Pca treatment has no significant effect on T 
cell trafficking to these organs. Comparison of traffick- 
ing in male and female mice, however, demonstrated 
that more cells accumulate in the spleens of female mice 
than in those of males. This was shown using both 51Cr 
and CMFDA, and was observed with both untreated and 
Pca-treated cells. Moreover, neutering the females de- 
creased splenic homing, suggesting that estrogens may 
play a role in this phenomenon. Together, these results 
support the contention that lymphoid homing of T cells 
is different in males and females, and that female sex 
steroids may contribute to this difference, possibly be- 
cause of an effect of estrogens on endothelial adhesion 
molecule expression, as previously shown (10). Further 
experiments using exogenous administration of estro- 
gens and measuring trafficking and endothelial adhesion 
molecule expression in neutered and control mice would 
help test this possibility. 
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We also determined the significance of splenic 
homing by comparing disease manifestations in normal 
mice with those in splenectomized mice. Splenectomy 
abrogated the autoantibody response, and splenecto- 
mized mice did not develop renal or liver disease. This 
indicates that the spleen is crucial for these disease 
manifestations, and suggests that the spleen is the site 
where D10 cells interact with other cells of the immune 
system, lysing macrophages and secreting cytokines such 
as IL-4 and IL-6 (4-6). Combined with other splenic T 
cells, this appears to result in the development of 
anti-DNA antibodies and other disease manifestations, 
by mechanisms similar to those producing chronic graft- 
versus-host disease (7,8). This is consistent with the 
findings of other studies, in which the spleen and splenic 
lymphocytes have been implicated in the development of 
lupus-like autoimmune diseases, although earlier sple- 
nectomy was required in these models (21-23). We have 
also previously observed that IgM anti-DNA antibodies 
appear first, and isotype switching to IgG occurs -4 
weeks later (ref. 5 and unpublished results), further 
supporting a role for T cells in the development of these 
autoantibodies. The lack of glomerulonephritis in the 
splenectomized group may be attributed to the absence 
of autoantibodies, since this manifestation is associated 
with immune complex deposition (43). Moreover, oth- 
ers, in addition to our group, have shown the importance 
of anti-DNA antibodies in the pathogenesis of lupus 
nephritis (24-26). 
However, the pathogenesis of the liver disease in 
this model appears to be different. We could find no 
evidence for liver autoantibodies, either by staining for 
Ig deposition, or by indirect immunofluorescence using 
sera from animals with liver disease and using male and 
female liver tissue from healthy animals. The observa- 
tion that the spleen is required for the liver disease 
manifestations also suggests that cells homing to the 
liver are probably not directly responsible for the auto- 
immune lesions. It is possible that the D10 cells trigger 
the development of other autoreactive lymphocytes in 
the spleen, which, in turn, contributes to the liver 
abnormalities. 
In summary, homing to the spleen appears to be 
important for the development of autoantibodies, renal 
disease, and liver lesions. Significantly more T cells 
accumulate in the spleens of female mice than in those 
of males, and the degree of uptake varies directly with 
the severity of the autoantibody response and liver 
disease. Finally, oophorectomy results in fewer cells 
accumulating in the spleen, and in milder disease. To- 
gether, these results suggest that the female-specific 
increase in disease severity may be due to greater 
numbers of autoreactive D10 cells homing to the spleens 
of female mice. The results also suggest that autoreac- 
tive D10 cells cause autoimmunity by several mecha- 
nisms. Homing studies of longer duration, detailed 
characterization of the cells infiltrating the liver and 
lung, and studies on the effector mechanisms will be 
necessary to clarify the process by which autoreactive 
D10 cells cause tissue lesions in this system. 
Other interpretations have been considered. It is 
possible that trauma and stress associated with oopho- 
rectomy or splenectomy may have decreased the severity 
of some manifestations. However, 3 observations 
weaken this possibility. The surgery was performed at 
least 5 months prior to killing the mice. The immuno- 
logic effects of surgery are seen shortly after the opera- 
tion and are self-limited (27). It is unlikely that nonspe- 
cific effects of surgery, performed 5 or more months 
prior to studying the mice, would completely eliminate 
the autoantibody response, as was observed. Furthermore, 
other investigators have included sham-splenectomized 
mice as controls in studies on the effects of splenectomy, 
and have demonstrated little effect of the control oper- 
ation on Ig levels and antibody responses (28). Finally, 
those same studies have demonstrated that splenecto- 
mized mice are capable of mounting an antibody re- 
sponse by bone marrow B cells (28). Therefore, the lack 
of an autoantibody response in the splenectomized mice 
described in the present report provides further evi- 
dence that the spleen, rather than other sites such as the 
bone marrow, is where the autoreactive D10 cells inter- 
act with other cells of the host’s immune system. 
Another interpretation of these results is that 
cells killed during the injection process contribute to the 
autoantibody response by providing a source of chroma- 
tin as antigen. However, similar numbers of treated and 
untreated cells survived the injection, and only the 
autoreactive cells caused autoimmunity. Furthermore, 
we have reported that heat-killed autoreactive cells do 
not trigger autoimmunity (5).  For these reasons, it seems 
likely that viable autoreactive cells are responsible for 
the disease manifestations observed. 
These results thus support the contention that 
splenic homing of autoreactive cells can trigger an 
autoimmune disease in this system, and that there is a 
sex-specific difference in the number of cells homing to 
the spleen, which can explain the increased severity in 
female mice. This may have relevance to the striking 
sex-specific predilection that lupus has for women. It 
should also be noted that dramatic improvement in 
human lupus, including increased survival, has been 
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reported following splenectomy (29,30). Sex-specific 
homing of autoreactive T cells to splenic or peripheral 
lymphoid tissue in humans could play a role similar to 
the spleen in this murine model. Studies comparing 
endothelial adhesion molecule expression in lymphoid 
tissue from men and women would help confirm this 
hypothesis. 
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